Targeting a gene in pancreatic beta cells could disrupt the chain of events that leads to the immune system destroying those cells and causing type 1 diabetes. This new study looks at the role of the beta cells themselves in triggering autoimmunity. The research also raises the possibility that new medications could block the immune system from destroying beta cells and prevent type 1 diabetes from developing in at risk or early onset patients.